Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v3-FR
Language French French
Date Updated 2021-05-03 2021-05-03
Drug Identification Number 02236564 02236564
Brand name LOVENOX WITH PRESERVATIVE 300MG/3ML LOVENOX WITH PRESERVATIVE 300MG/3ML
Common or Proper name Lovenox Vial Lovenox Vial
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients ENOXAPARIN SODIUM ENOXAPARIN SODIUM
Strength(s) 100MG 100MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 1 1
ATC code B01AB B01AB
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2021-05-30 2021-05-30
Actual start date
Estimated end date 2021-06-30 2021-06-30
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Company comments Transportation delay - The transportation delay is due to the strike at the Montreal Port. In addition, overselling is leading to a limited supply of product. Allocation will be kept in place to mitigate the anticipated shortage. Transportation delay - The transportation delay is due to the strike at the Montreal Port. In addition, overselling is leading to a limited supply of product. Allocation will be kept in place to mitigate the anticipated shortage.
Health Canada comments